During the past decade, Southern Oregon Cardiology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Oregon Cardiology" #1 sponsor was "AtriCure, Inc." with 2 trials, followed by "Baim Institute for Clinical Research" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored and "CeloNova BioSciences, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Oregon Cardiology" #1 collaborator was "American College of Cardiology" with 1 trials as a collaborator, "Chiltern International Inc." with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Southern Oregon Cardiology" are "Atrial Fibrillation" (3 trials), "Cardiovascular Disease" (2 trials), "Cardiac Resynchronization Therapy" (1 trials), "Coronary Artery Disease" (1 trials) and "Defibrillators, Implantable" (1 trials). Many other conditions were trialed in "Southern Oregon Cardiology" in a lesser frequency.

Most popular intervention types in "Southern Oregon Cardiology" are "Device" (4 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "LARIAT + PVI" (2 trials), "COBRA PzF" (1 trials), "Edoxaban-based Regimen" (1 trials), "HeartLogic Sensors" (1 trials) and "Methotrexate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southern Oregon Cardiology" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Southern Oregon Cardiology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Southern Oregon Cardiology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southern Oregon Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".